Type 2 & other diabetes

Frequent Monitoring of Blood Glucose Levels via a Remote Patient Monitoring System Helps Improve Glycemic Control

Endocr PractPublished Randomised controlled trial

Authors' conclusion

The use of the Vivovitals platform may help to improve glycemic control among individuals with type 2 diabetes mellitus.

Study context

Population
Adults aged ≥18 years with uncontrolled T2D and hemoglobin A1c (HbA1c) ≥7.5% (58 mmol/mol) at baseline
Participants
78 adults
Comparison
Vivovitals diabetes platform vs usual clinical care
Primary endpoint
Change in HbA1c
Follow-up
12 weeks
Methodological detailsprospective, pragmatic, single-centre, double-arm
  • Prospective
  • Pragmatic
  • Single-centre
  • Double-arm

Primary result

HbA1c reduction

Cohen d

0.62

Change by group

Control

0.474

average reduction · 95% CI −0.425–-0.523 · %

Intervention

1.70

average reduction · 95% CI −1.02–-2.39 · %

As reported in the abstract

Original publication

Frequent Monitoring of Blood Glucose Levels via a Remote Patient Monitoring System Helps Improve Glycemic Control. Endocr Pract. Published 23 March 2023. doi:10.1016/j.eprac.2023.03.270

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.